Fcf Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fcf Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$692.45 - $844.37 $20,773 - $25,331	-30 Reduced 2.7%	1,083 $891,000
Q2 2023 Jul 19, 2023	SELL	$700.03 - $830.35 $110,604 - $131,195	-158 Reduced 12.43%	1,113 $799,000
Q1 2023 Apr 19, 2023	BUY	$680.49 - $826.97 $108,878 - $132,315	160 Added 14.4%	1,271 $1.04 Million
Q4 2022 Feb 03, 2023	SELL	$705.89 - $766.39 $16,941 - $18,393	-24 Reduced 2.11%	1,111 $801,000
Q3 2022 Oct 12, 2022	SELL	$573.97 - $724.32 $45,917 - $57,945	-80 Reduced 6.58%	1,135 $781,000
Q2 2022 Jul 20, 2022	BUY	$548.35 - $738.84 $666,245 - $897,690	1,215 New	1,215 $718,000
Q4 2020 Jan 12, 2021	SELL	$478.3 - $607.98 $1.26 Million - $1.6 Million	-2,625 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$544.75 - $658.21 $516,423 - $623,983	948 Added 56.53%	2,625 $1.58 Million
Q2 2020 Jul 10, 2020	BUY	$493.32 - $643.92 $827,297 - $1.08 Million	1,677 New	1,677 $1.04 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fcf Advisors LLC with notifications on news.